DRI-C21041 is a CD40/CD40L interaction inhibitor, with an IC 50 of 0.31 μM. DRI-C21041 inhibits the immune response induced by alloantigen.
Products | Products > Disease Areas > Inflammation or Immune System Disease | Products > Signaling Pathways > Apoptosis | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > TNF Receptor
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.